It remains a challenging task to elucidate whether the manipulation of NFATc1 and IL-10 activities, alone or together with those of IL-17 and IL-23, will be of benefit for patients suffering from psoriasis and other autoimmune diseases. The gene discussed is IL17A; the disease is psoriasis.